Ethypharm is a leading mid-sized international pharmaceutical company, with strong European roots, that manufactures and provides essential drugs, with a focus on hospital care, central nervous system (severe pain and addiction) and internal medicine.
Our commitment is to improve patients' lives and make a positive impact on society and the environment.
Ethypharm has 1,700 employees dedicated to its various pharmaceutical activities, of which 1400 are in industrial operations.
Our six production sites located in France, the UK, Spain, and China have expertise in injectables and complex oral solid forms.
With a global presence in 68 countries, the company markets its products directly in Europe and China, and has strategic partnerships in the EMEA, NA, LATAM and APAC markets.
Ethypharm works closely with the authorities and healthcare professionals to ensure that its medicines are used appropriately and that patients have access to them.
To find out more about Ethypharm, visit http://www.ethypharm.com and follow us on LinkedIn.
Industry
Pharmaceutical Manufacturing, Pharmaceutical products, Medical and pharmaceutical research, Research and testing, IT, Internet, R&D, Pharmaceuticals research and development, Immunology research and development, Medical technology research and development, Sous-traitance pour l'industrie pharmaceutique et cosmétique, Parachimie
HQ Location
194, Bureaux de la Colline
Saint-Cloud Cedex, 92213, FR
Keywords
AddictioPaiCritical CareCNSHospital Injectablesevere paiHospital careInternal Medicine